News Snapshot:
In this picture taken on April 29, 2020, an engineer works at the Quality Control Laboratory on an experimental vaccine for the COVID-19 coronavirus at the Sinovac Biotech facilities in Beijing. Nicolas Asfouri | AFP | Getty Images Sinovac Biotech said on Saturday that its unit's Covid-19 vaccine has been formally approved for use by the general public by China's medical products regulator. It marks the second Covid-19 vaccine green-lighted for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December. Prior to the approvals, both...
